Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$8.41 - $10.34 $106,865 - $131,390
-12,707 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$8.33 - $12.96 $105,849 - $164,682
12,707 New
12,707 $121,000
Q4 2021

Feb 10, 2022

SELL
$7.42 - $11.05 $93,855 - $139,771
-12,649 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$6.77 - $14.41 $85,633 - $182,272
12,649 New
12,649 $94,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $658M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.